Diabetes Obes Metab 19(3):33647 Buse JB, Klonoff DC, Nielsen LL, Guan X, Bowlus CL, Holcombe JH et al (2007) Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
Patients with certain genetic markers may reach optimal weight loss at lower doses like 1.0 mg, while others benefit from higher doses
Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid
Circumstantial evidence 2 suggests oxidative stress is the key factor behind graying hair and hair loss
There is no single 'good' number HRV is highly individual and declines gradually with age
Consult with your doctor first before supplementation